Chairman and CEO
Mon, Jun 22, 2026
Jun 22
204,815 shares @ $9.35
Decreased holdings by -7.10%
4th largest trade (out of 7)
Planned (10b5-1)Large Trade
“This transaction was effected pursuant to a Rule 10b5-1 plan to sell 2.5 million shares adopted by the reporting person on March 16, 2026. A Form 144 covering the first tranche of 1,699,007 subordinate voting shares was filed on June 17, 2026. The second tranche of remaining shares will be eligible for sale after September 15, 2026.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 21% above 200-day moving average
Small Cap stock — insider trades carry more weight
TCNNFTrulieve Cannabis Corp.
ManufacturingMedicinal Chemicals & Botanical Products
1D0.00%
1W0.00%
1M-1.12%
3M—
6M—
1Y—